The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 37 | — | 20.1x | Near average | |
Growth | 69 | 54.4% | 5.6% | Above average | |
Quality | 15 | -164.6% | 7.6% | Below average | |
Safety | 44 | -0.1x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
InspireMD, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy InspireMD, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
InspireMD stock saw stability in its average price target at 4.5 dollars, with a new analyst entering coverage during the past seven days, bringing the total number of analysts to two. Despite the steady average, there is a wide gap in estimates (Dispersion) between a low of 3 and a high of 6 dollars, reflecting a variance in the assessment of operational risks versus market opportunities, especially as losses in earnings per share (EPS) continue according to financial estimates.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.